Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease

A Tarnutzer1, F Andreoni1, N Keller1

  • 1Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Abstract

Insights

Intravenous immunoglobulin (IVIG) effectively reduced disease severity in a mouse model of necrotizing fasciitis (NF) by inhibiting key virulence factors. These findings suggest IVIG may benefit patients with invasive Streptococcus pyogenes infections.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Microbiology

Background:

  • Streptococcus pyogenes causes severe invasive infections like necrotizing fasciitis (NF).
  • Current NF treatment involves antibiotics and surgery, with adjunctive intravenous immunoglobulin (IVIG) therapy explored for streptococcal toxic shock syndrome.
  • The efficacy of IVIG in invasive infections remains unclear due to limited prospective studies.

Purpose of the Study:

  • To evaluate the impact of IVIG on Streptococcus pyogenes virulence factor activity.
  • To assess IVIG's therapeutic potential in a murine model of NF.
  • To investigate IVIG's effect on virulence factors in vitro, ex vivo in patients, and in vivo.

Main Methods:

  • Investigated IVIG's effect on streptolysin O (SLO), streptodornase 1 (Sda1), S. pyogenes cell envelope protease, and streptococcal pyrogenic exotoxin B in vitro and in patient sera.
  • Assessed clinical outcomes in a murine NF model following IVIG administration.
  • Measured changes in virulence factor activity and antibody titers in patient sera post-IVIG treatment.

Main Results:

  • In vitro, IVIG inhibited multiple streptococcal virulence factors.
  • IVIG treatment significantly reduced skin lesion size and SLO activity in a murine NF model.
  • Patient sera showed increased specific antibodies against SLO and Sda1 after IVIG, reducing their activity.

Conclusions:

  • IVIG demonstrated a clear reduction in disease severity in a mouse model of NF.
  • IVIG effectively inhibited streptococcal virulence factors in both mouse and human samples.
  • Findings suggest IVIG could be a beneficial adjunctive therapy for invasive Streptococcus pyogenes infections, including NF.

Related Concept Videos

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.5K
Factors Affecting Activity Coefficient01:17

Factors Affecting Activity Coefficient

The extended Debye-Hückel equation indicates that the activity coefficient of an ion in an aqueous solution at 25°C depends on three partially interdependent properties: the ionic strength of the solution, the charge of the ion, and the ion size. 
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a...
1.6K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.4K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K